• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏多糖贮积症 III 型(Sanfilippo 综合征)和特发性发育迟缓、注意缺陷多动障碍或自闭症谱系障碍的误诊。

Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder.

机构信息

Department of Paediatrics, Academic Medical Centre, Amsterdam, The Netherlands.

出版信息

Acta Paediatr. 2013 May;102(5):462-70. doi: 10.1111/apa.12169. Epub 2013 Feb 6.

DOI:10.1111/apa.12169
PMID:23336697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3654162/
Abstract

UNLABELLED

Mucopolysaccharidosis III is a rare genetic disease characterized by progressive cognitive decline and severe hyperactivity that does not respond to stimulants. Somatic features are relatively mild. Patients are often initially misdiagnosed as having idiopathic developmental delay, attention deficit/hyperactivity disorder and/or autism spectrum disorders, putting them at risk for unnecessary testing and treatments.

CONCLUSION

Children with developmental or speech delay, especially those with a characteristic somatic feature or behavioural abnormalities, should be screened for MPS III.

摘要

未注明

黏多糖贮积症 III 型是一种罕见的遗传疾病,其特征是认知能力逐渐下降和严重的多动,而多动对兴奋剂没有反应。躯体特征相对较轻。患者通常最初被误诊为特发性发育迟缓、注意力缺陷多动障碍和/或自闭症谱系障碍,使他们面临不必要的检查和治疗的风险。

结论

有发育或言语迟缓的儿童,尤其是有特征性躯体特征或行为异常的儿童,应进行黏多糖贮积症 III 型的筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a23/3654162/81921922c37b/apa0102-0462-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a23/3654162/7ba4716d27ab/apa0102-0462-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a23/3654162/81921922c37b/apa0102-0462-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a23/3654162/7ba4716d27ab/apa0102-0462-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a23/3654162/81921922c37b/apa0102-0462-f2.jpg

相似文献

1
Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder.黏多糖贮积症 III 型(Sanfilippo 综合征)和特发性发育迟缓、注意缺陷多动障碍或自闭症谱系障碍的误诊。
Acta Paediatr. 2013 May;102(5):462-70. doi: 10.1111/apa.12169. Epub 2013 Feb 6.
2
From hypertransaminasemia to mucopolysaccharidosis IIIA.从高转氨酶血症到ⅢA型黏多糖贮积症
Ital J Pediatr. 2014 Dec 2;40:97. doi: 10.1186/s13052-014-0097-z.
3
[Sanfilippo Syndrome].[桑菲利波综合征]
Vestn Ross Akad Med Nauk. 2015(4):419-27.
4
Hyperactivity, unexplained speech delay, and coarse facies--is it Sanfilippo syndrome?多动、不明原因的语言发育迟缓及粗糙面容——这是桑菲利波综合征吗?
J Child Neurol. 2014 Aug;29(8):NP9-12. doi: 10.1177/0883073813491627. Epub 2013 Jun 12.
5
Symptoms of Autism Spectrum Disorder (ASD) in Individuals with Mucopolysaccharide Disease Type III (Sanfilippo Syndrome): A Systematic Review.黏多糖贮积症 III 型(Sanfilippo 综合征)个体的自闭症谱系障碍(ASD)症状:系统评价。
J Autism Dev Disord. 2017 Nov;47(11):3620-3633. doi: 10.1007/s10803-017-3262-6.
6
Sanfilippo syndrome: Overall review.桑菲利波综合征:全面综述。
Pediatr Int. 2015 Jun;57(3):331-8. doi: 10.1111/ped.12636.
7
Changes in maladaptive behaviors from midchildhood to young adulthood in autism spectrum disorder.自闭症谱系障碍患者从中年到青年期适应不良行为的变化。
Am J Intellect Dev Disabil. 2011 Sep;116(5):381-97. doi: 10.1352/1944-7558-116.5.381.
8
Role of ESSENCE for preschool children with neurodevelopmental disorders.ESSENCE对患有神经发育障碍的学龄前儿童的作用。
Brain Dev. 2013 Feb;35(2):128-32. doi: 10.1016/j.braindev.2012.06.011. Epub 2012 Aug 6.
9
Diagnoses commonly missed in childhood. Long-term outcome and implications for treatment.儿童期常见的漏诊疾病。长期预后及对治疗的影响。
Psychiatr Clin North Am. 1998 Dec;21(4):927-40, viii. doi: 10.1016/s0193-953x(05)70050-2.
10
Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders.神经发育障碍诊断及预后的电生理生物标志物
Curr Opin Neurol. 2015 Apr;28(2):110-6. doi: 10.1097/WCO.0000000000000181.

引用本文的文献

1
Exploring Molecular and Phenotypic Characteristics of Arg234Gly and Asp312Asn Variants.探索Arg234Gly和Asp312Asn变体的分子和表型特征。
Mol Syndromol. 2025 Aug;16(4):342-353. doi: 10.1159/000542367. Epub 2024 Nov 6.
2
Autism spectrum disorder and inherited metabolic diseases: are there any common features?自闭症谱系障碍与遗传性代谢疾病:有哪些共同特征?
Pediatr Endocrinol Diabetes Metab. 2025;31(1):30-34. doi: 10.5114/pedm.2025.148397.
3
Transplantation of Wild-Type Hematopoietic Stem and Progenitor Cells Improves Disease Phenotypes in a Mucopolysaccharidosis IIIC Mouse Model.

本文引用的文献

1
Experiences of parents and patients with the timing of Mucopolysaccharidosis type I (MPS I) diagnoses and its relevance to the ethical debate on newborn screening.MPS I 诊断时机的父母和患者体验及其与新生儿筛查伦理辩论的相关性。
Mol Genet Metab. 2012 Nov;107(3):501-7. doi: 10.1016/j.ymgme.2012.08.008. Epub 2012 Aug 16.
2
Gene expression-targeted isoflavone therapy.基因表达靶向异黄酮疗法。
IUBMB Life. 2012 Apr;64(4):307-15. doi: 10.1002/iub.1007. Epub 2012 Feb 23.
3
An improved method for glycosaminoglycan analysis by LC-MS/MS of urine samples collected on filter paper.
野生型造血干细胞和祖细胞移植改善黏多糖贮积症IIIC小鼠模型的疾病表型。
Cell Transplant. 2025 Jan-Dec;34:9636897251323966. doi: 10.1177/09636897251323966. Epub 2025 Mar 24.
4
Behavioural disorders and sleep problems in Sanfilippo syndrome: overlaps with some other conditions and importance indications.桑菲力波综合征中的行为障碍与睡眠问题:与其他一些病症的重叠及重要指征
Eur Child Adolesc Psychiatry. 2025 Jun;34(6):1795-1816. doi: 10.1007/s00787-025-02661-5. Epub 2025 Mar 15.
5
D1 dopamine receptor antagonists as a new therapeutic strategy to treat autistic-like behaviours in lysosomal storage disorders.D1多巴胺受体拮抗剂作为治疗溶酶体贮积症中自闭症样行为的一种新治疗策略。
Mol Psychiatry. 2025 Jan 26. doi: 10.1038/s41380-025-02904-6.
6
Development and longitudinal neurocognitive functioning in mucopolysaccharidosis type IIIC: a case study.IIIC型黏多糖贮积症的发育及纵向神经认知功能:一项病例研究
J Appl Genet. 2024 Dec 30. doi: 10.1007/s13353-024-00934-4.
7
Generation of an induced pluripotent stem cell line (TRNDi042-A) from a Mucopolysaccharidosis type IIIB patient with homozygous p. R626X (c. 1876C > T) mutation in the NAGLU gene.从一名患有NAGLU基因纯合p.R626X(c.1876C>T)突变的IIIB型黏多糖贮积症患者中诱导产生多能干细胞系(TRNDi042-A)。
Stem Cell Res. 2024 Dec;81:103612. doi: 10.1016/j.scr.2024.103612. Epub 2024 Nov 16.
8
Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB.黏多糖贮积症 IIIB 型小鼠模型中疾病早期标志物的特征。
J Neurodev Disord. 2024 Apr 17;16(1):16. doi: 10.1186/s11689-024-09534-z.
9
[Natural history of mucopolysaccharidosis type III in a series of Colombian patients].[哥伦比亚一系列黏多糖贮积症III型患者的自然病史]
Rev Neurol. 2024 Mar 16;78(6):171-177. doi: 10.33588/rn.7806.2023281.
10
Economic Burden of Sanfilippo Syndrome in the United States.美国桑菲利波综合征的经济负担
Res Sq. 2023 Nov 1:rs.3.rs-3001450. doi: 10.21203/rs.3.rs-3001450/v1.
基于滤纸条采集尿液样本的 LC-MS/MS 法进行糖胺聚糖分析的改良方法。
Clin Chim Acta. 2012 Apr 11;413(7-8):771-8. doi: 10.1016/j.cca.2012.01.012. Epub 2012 Jan 20.
4
Genistein in Sanfilippo disease: a randomized controlled crossover trial.Sanfilippo 病中染料木黄酮:一项随机对照交叉试验。
Ann Neurol. 2012 Jan;71(1):110-20. doi: 10.1002/ana.22643.
5
Neonatal screening for lysosomal storage disorders.新生儿溶酶体贮积症筛查
Lancet. 2012 Jan 28;379(9813):294-5. doi: 10.1016/S0140-6736(11)61744-3. Epub 2011 Nov 29.
6
Validation of an LC-MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome.用于检测来自硫酸角质素的相关二糖作为黏多糖贮积症IVA型综合征生物标志物的液相色谱-串联质谱法检测的验证。
Bioanalysis. 2011 Aug;3(16):1855-66. doi: 10.4155/bio.11.172.
7
Preventing mucopolysaccharidosis type II (Hunter syndrome): PGD and establishing a Hunter (46, XX) stem cell line.预防黏多糖贮积症 II 型(亨特综合征):PGD 和建立亨特(46, XX)干细胞系。
Prenat Diagn. 2011 Sep;31(9):853-60. doi: 10.1002/pd.2786. Epub 2011 Jun 27.
8
Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome).黏多糖贮积症 III 型(Sanfilippo 综合征)患者的认知发展。
Orphanet J Rare Dis. 2011 Jun 20;6:43. doi: 10.1186/1750-1172-6-43.
9
Evaluation of miglustat treatment in patients with type III mucopolysaccharidosis: a randomized, double-blind, placebo-controlled study.评价 III 型黏多糖贮积症患者接受米格列奈特治疗的效果:一项随机、双盲、安慰剂对照研究。
J Pediatr. 2011 Nov;159(5):838-844.e1. doi: 10.1016/j.jpeds.2011.04.040. Epub 2011 Jun 12.
10
Musculoskeletal manifestations of Sanfilippo Syndrome (mucopolysaccharidosis type III).桑菲利波综合征(Ⅲ型黏多糖贮积症)的肌肉骨骼表现
J Pediatr Orthop. 2011 Jul-Aug;31(5):594-8. doi: 10.1097/BPO.0b013e31821f5ee9.